# The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy

> **NCT02271555** · PHASE4 · UNKNOWN · sponsor: **Inonu University** · enrollment: 58 (estimated)

## Conditions studied

- Haemodynamic Rebound

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Remifentanil
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02271555
- **Lead sponsor:** Inonu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2014-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271555, "The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02271555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*